SAREPTA THERAPEUTICS, INC. Operating Lease Liability
SAREPTA THERAPEUTICS, INC. (SRPT) had Operating Lease Liability of $210.57 million as of 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-03-02
- 2025-12-31: Operating Lease, Liability $210.57M.
- 2024-12-31: Operating Lease, Liability $205.75M.
- 2023-12-31: Operating Lease, Liability $158.81M.
- 2022-12-31: Operating Lease, Liability $73.07M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-12-31 | $210.57M 10-K · filed 2026-03-02 |
| 2024-12-31 | $205.75M 10-K · filed 2025-02-28 |
| 2023-12-31 | $158.81M 10-K · filed 2024-02-28 |
| 2022-12-31 | $73.07M 10-K · filed 2023-02-28 |
| 2021-12-31 | $56.56M 10-K · filed 2022-03-01 |
| 2020-12-31 | $101.30M 10-K · filed 2021-03-01 |
| 2019-12-31 | $55.57M 10-K · filed 2020-02-26 |
| 2019-09-30 | $57.34M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $57.37M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $58.93M 10-Q · filed 2019-05-08 |
| 2019-01-01 | $60.10M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |